25

Listed companies

15

Private companies

30

Insiders

Relation chart of related listed companies: Genscript Biotech Corporation

Active Relations

Past Relations

Relationship chart for related private companies: Genscript Biotech Corporation

Active Relations

Past Relations

Related private companies: Genscript Biotech Corporation

The Chartered Governance Institute

Miscellaneous Commercial Services

The Hong Kong Institute of Chartered Secretaries

Miscellaneous Commercial Services

Nanjingjinsirui Science & Technology Biology Corp.

Biotechnology

GenScript (Hong Kong) Ltd.

Medical/Nursing Services

Bestzyme Biotech Corp.

Bestzyme Biotech Ltd.

Bestzyme Biotech USA, Inc.

Legend Biotech Ltd.

Genscript Biotech Ltd.

GenScript International Ltd.

GenScript USA, Inc.

Medical Specialties

Sunpower Technology (Jiangsu) Co., Ltd.

Industrial Machinery

SWCS Corporate Services Group (Hong Kong) Ltd.

Miscellaneous Commercial Services

Probio Technology Ltd.

Miscellaneous

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major8
Miscellaneous Commercial Services6
Biotechnology3
Industrial Machinery2
Medical/Nursing Services2
Engineering & Construction2
Miscellaneous1
Apparel/Footwear1
Agricultural Commodities/Milling1
Restaurants1

Countries of related companies

China22
United States7
Hong Kong5
British Virgin Islands3
United Arab Emirates1
Cayman Islands1
United Kingdom1
Logo Genscript Biotech Corporation
Genscript Biotech Corp is an investment holding company principally engaged in the manufacture and sale of life science research products and services. The Company operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
6,165